Ticker Details
Design Therapeutics, Inc.
IPO Date:	March 29, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$953.12M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.39 | 4.14%
Avg Daily Range (30 D):	$0.40 | 2.98%
Avg Daily Range (90 D):	$0.54 | 4.14%

Institutional Daily Volume
Avg Daily Volume:	.27M
Avg Daily Volume (30 D):	.4M
Avg Daily Volume (90 D):	.7M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	461
Avg Institutional Trade:	$1.53M
Avg Institutional Trade (30 D):	$.83M
Avg Institutional Trade (90 D):	$1.1M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.88M
Avg Closing Trade (30 D):	$.83M
Avg Closing Trade (90 D):	$1.27M
Avg Closing Volume:	149.83K

News

May 18, 2026 @ 11:00 AM Design Therapeutics Announces Four-Week IV Data fr... Source: Na

May 17, 2026 @ 8:00 PM Design Therapeutics to Host Investor Webcast to Re... Source: Na

Nov 26, 2025 @ 1:00 PM Design Therapeutics to Participate in Upcoming Inv... Source: Renee Leck

May 7, 2024 @ 10:30 AM Design Therapeutics to Participate in the 2024 RBC... Source: Design Therapeutics, Inc.

Mar 26, 2024 @ 11:37 AM Design Therapeutics And 2 Other Stocks Under $5 In... Source: Avi Kapoor

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.18	$-.32	$-.29
Diluted EPS	$-1.18	$-.32	$-.29
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-70.8M	$-20.17M	$-17.64M
Operating Income / Loss	$-79.36M	$-22.18M	$-19.71M
Cost of Revenue
Net Cash Flow	$-6.8M	$.14M	$-4.09M
PE Ratio